Somatostatin therapy in L-asparaginase-induced pancreatitis.

L-Asparaginase-induced pancreatitis is an uncommon but potentially lethal complication. An 8-year-old girl with acute lymphoblastic leukaemia developed acute pancreatitis following treatment with asparaginase. Clinical and laboratory improvements were evident after treatment with somatostatin, with no complications of pancreatitis. Induction therapy for the leukaemia was able to be continued and complete remission was documented during the course of pancreatitis and somatostatin treatment, suggesting a beneficial role of somatostatin in the management of asparaginase-induced pancreatitis.

[1]  S. Richards,et al.  Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia , 1993, British journal of haematology.

[2]  S. Richards,et al.  Non-randomised study comparing toxicity of Escherichia coli and Erwinia asparaginase in children with leukaemia. , 1990, Medical and pediatric oncology.

[3]  J. Wong,et al.  Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. , 1989, Gut.

[4]  D. W. Day,et al.  Effects of somatostatin and a long‐acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat , 1985, The British journal of surgery.

[5]  R. Gelber,et al.  Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. , 1983, Cancer research.

[6]  P. Lam-po-tang,et al.  FATAL CASE OF L-ASPARAGINASE INDUCED PANCREATITIS , 1982, The Lancet.

[7]  T. Adrian,et al.  The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. , 1981, The Journal of clinical endocrinology and metabolism.

[8]  F. Kern,et al.  Drug-induced pancreatitis: a critical review. , 1980, Gastroenterology.

[9]  S. Raptis,et al.  Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog. , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[10]  A. Greenstein,et al.  Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst , 1979, Cancer.

[11]  J. Chessells,et al.  Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL). , 1979, Medical and pediatric oncology.

[12]  S. Raptis,et al.  Effects of Somatostatin on Exocrine and Endocrine Pancreatic Function Stimulated by Intestinal Hormones in Man* , 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  M. Slavik,et al.  The "other" asparaginase. , 1976, Medical and pediatric oncology.

[14]  Tan Cl,et al.  Acute haemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukaemia --a case report. , 1974 .

[15]  R. Baehner,et al.  Latent onset of clinical pancreatitis in children receiving l‐asparaginase therapy , 1974, Cancer.

[16]  L. Blumgart,et al.  Letter: Glucagon therapy in acute pancreatitis. , 1974, British medical journal.

[17]  V. Land,et al.  Toxicity of L‐asparaginase in children with advanced leukemia , 1972 .

[18]  P. Carbone,et al.  L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. , 1969, The New England journal of medicine.

[19]  A. North,et al.  Physicochemical Studies of L-Asparaginase from Erwinia carotovora , 1969, Nature.

[20]  F. Stirpe,et al.  The regulation of L-asparaginase activity in rats and mice. Effects of normal and malignant growth, of sex and of dietary changes. , 1969, The Biochemical journal.

[21]  L. Old,et al.  Asparagine Synthetase Activity of Mouse Leukemias , 1968, Science.